Pharma and Food Thought Leaders Set to Converge in Amsterdam Next April 2011

AMSTERDAM, August 20, 2010 - Pharma-Nutrition (www.pharma-nutrition.com/news.asp), the new
international scientific conference organised by Elsevier, the leading
publisher of scientific, technical and medical information products and
services, aims to discuss the latest research, concepts and practical
applications of medical nutrition in patient treatments, disease management
and patient outcomes. Pharma-Nutrition is set to take place next 18-20 April
at Amsterdam's NH Grand Hotel Krasnapolsky. The convergence of both
pharmacology and food science professionals, will make this the first
platform dedicated to the scientific interface between pharma and food.

The Scientific Committee composed of acknowledged opinion leaders in both
food science and pharmacology from across the spectrum of therapeutic
research areas will work alongside organisers to develop a multidisciplinary
programme, covering areas such as oncology, immunology, neurology and
cardiovascular disease. The Conference Chairman, Professor Johan Garssen,
University of Utrecht, commented, "We are starting to see a real convergence
of the two areas of pharma and food and it is their complementary values
which can be applied to medical nutrition in order to help address the ever
growing burden of diseases in modern society."

"I am so pleased that we have been able to bring together for the first
time such an outstanding group of preclinical and clinical experts from both
pharma and nutrition," said Dr. Jaap van Harten, Elsevier Executive
Publisher. "This conference will provide the platform for participants to
share and discuss their latest research on this important area of science,"
he remarked.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact

    Rachel Martin
    +31(0)20-485-2467
    r.martin@elsevier.com

Media Contact: Rachel Martin, +31(0)20-485-2467, r.martin at elsevier.com .